Pharmaceuticals
Two portfolios—one GOP, 1 Democrat—make predictions about the U.S. midterms
ShareShare Posting by using FacebookShare Article via TwitterShare Report by way of LinkedInShare Posting by using E mail Electricity, defense, insurance coverage and pharmaceutical stocks will advantage from insurance policies set by the Republicans. Clean up electricity is a winner if the Democrats excel. As well as, the latest on the midterms and help to […]
Read More
4 of our stocks are in the news. Here’s the Club’s take on each development
Four of our Club holdings — Costco Wholesale (COST), Amazon (AMZN), Humana (HUM) and Bausch Health (BHC) — were in the news Thursday. Here’s how we feel about the developments. Costco The news: Costco reported sales for the retail month of October after the closing bell Wednesday evening. In the four-week period, net sales increased 7.7% […]
Read More
CVS Health raises outlook as third quarter results beat estimates
Rafael Henrique | Lightrocket | Getty Images CVS Health reported third quarter earnings Wednesday morning that beat Wall Street’s expectations. Here’s how the pharmacy giant performed compared to Wall analysts’ estimates, according to Refinitiv: Earnings per share $2.09 vs. $1.99, expected. Revenue $81.16 billion vs. $76.75 billion, expected. It’s the third consecutive quarter in which […]
Read More
Eli Lilly’s guidance cut is about the strong dollar, not weakening fundamentals, CEO says
Eli Lilly (LLY) CEO David Ricks on Tuesday expressed optimism around the drugmaker’s innovation pipeline Tuesday, a stance we share despite the Club holding’s cluttered quarterly report issued earlier in the day . “The underlying fundamentals of the business are really strong,” Ricks said in a CNBC interview with Jim Cramer. “Seventy percent of our […]
Read More
Pfizer RSV vaccine given to pregnant mothers is effective at protecting newborns, company’s data shows
Pfizer’s vaccine against respiratory syncytial virus, or RSV, is highly effective at protecting newborns when the shot is given to the mothers late in their pregnancy, according to clinical trial data published Tuesday. RSV is a common respiratory virus that generally causes mild cold-like symptoms, but it can be dangerous for infants younger than 6 […]
Read More
More than 100,000 Americans are waiting for an organ transplant
There are more than 100,000 people in the United States waiting for an organ transplant, according to the United Network for Organ Sharing, known as UNOS. “I was born Type 1 diabetic,” said Patrick McGlone, who received a dual kidney-pancreas transplant in June 2021. “There was always the word transplant thrown around. But I never […]
Read More
Jim Cramer says to buy shares of Danaher on the dip
CNBC’s Jim Cramer on Friday advised investors to add Danaher to their shopping lists for next week after it reported third-quarter results. “You’re now getting a chance to buy one of the best-run companies in the world at a big discount. I think you’ve got to take advantage of this pullback [next] Monday morning, because […]
Read More
CDC group endorses adding Covid shots to recommended vaccine schedule
An advisory committee to the Centers for Disease Control and Prevention voted Thursday in favor of adding the Covid vaccine to the recommended immunization schedule for children and adults. Children 6 months and older, as well as adults, should get the Covid vaccine, plus boosters, when they are eligible for it, the Advisory Committee on Immunization Practices […]
Read More
FDA panel recommends revoking the approval of controversial drug intended to prevent premature birth
An advisory panel to the Food and Drug Administration voted Wednesday to take a drug intended to prevent premature births off the market, saying that it remains doubtful that the drug works. The recommendation, in a 14-1 vote, from the agency’s Obstetrics, Reproductive and Urologic Drugs Advisory Committee closed a three-day meeting on the clinical […]
Read More
FDA authorizes Novavax’s Covid shots as mix-and-match booster to Pfizer or Moderna
The Food and Drug Administration has authorized Novavax‘s Covid boosters for adults in the U.S., including for people who received Pfizer’s or Moderna’s shots as their primary series. The authorization of Novavax’s booster could significantly increase the role that its shot plays in U.S. vaccination efforts. Up until now, Novavax’s vaccine was only authorized as […]
Read More